Replies to post #39537 on Humanigen Inc (fka HGENQ)

[cowtown jay]

Novavax just issued a PR saying:

"PR NEWSWIRE
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall"

https://newsfilter.io/latest/fda-approvals

They're up 1.3% today on the excellent news.

We're up 6 - 20% with no PR.

I think both valuations simply reflect that regulators feel empowered to abuse their discretionary authority with impunity.

But this is a big world. It is not prepared with a proactive virulent response plan, as lenz is singularly essential to develop, preferably in an exclusive collaboration with Novavax.

Novavax recently announced:

"U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine
Feb 13, 2023"

https://ir.novavax.com/2023-02-13-U-S-Government-and-Novavax-Extend-Partnership,-Securing-Up-to-1-5-Million-Additional-Doses-of-Novavax-COVID-19-Vaccine

What SHOULD happen is that the lenz/vaccine/anti-viral cocktail should be the standard of care (SOC) for covid prevention. At the least, until that truth becomes self-evident, the lenz cocktail should be extended to family members of infected patients as a post-exposure prophylaxis. It should likewise be extended to seniors and those who are immuno-compromised as a pre-exposure prophylaxis.